1. Introduction {#sec1-ijerph-17-01969}
===============

In developing and developed countries, air pollution has already become an important health issue. Several factors, such as urbanization, industrialization, heavy traffic, or establishment of thermal power stations, result in air pollution in several countries. Primarily, lung cancer is considered the major severe disease caused by air pollution \[[@B1-ijerph-17-01969],[@B2-ijerph-17-01969]\]. Notably, accumulating evidence shows that chronic exposure to air pollution is associated with not only respiratory diseases but also non-lung cancers \[[@B3-ijerph-17-01969],[@B4-ijerph-17-01969]\] and cardiovascular \[[@B5-ijerph-17-01969],[@B6-ijerph-17-01969]\], inflammatory \[[@B7-ijerph-17-01969],[@B8-ijerph-17-01969]\], and neurodegenerative diseases \[[@B9-ijerph-17-01969],[@B10-ijerph-17-01969]\] including age-related macular degeneration (AMD) \[[@B11-ijerph-17-01969]\].

Sensorineural hearing loss (SHL) is defined as the damage, degeneration, or loss of the cochlear hair cells (HCs) \[[@B12-ijerph-17-01969],[@B13-ijerph-17-01969]\] or spiral ganglion neurons \[[@B14-ijerph-17-01969],[@B15-ijerph-17-01969],[@B16-ijerph-17-01969]\] in the auditory system. The majority of SHL patients are diagnosed with congenital SHL including syndromic and non-syndromic SHL. It has been shown that a total of 70--100 genetic loci are associated with SHL. These genetic loci are usually found in genes responsible for signal transduction, membrane ion channel expression, HC development, and aging processes \[[@B13-ijerph-17-01969]\]. Most of the genes are directly related to the function of the outer HCs in fine-tuning incoming sound waves. Currently, hearing aids and cochlear implants are clinically beneficial in restoring the hearing function of patients with congenital SHL. However, Food and Drug Administration-approved drugs used to treat congenital or degenerative SHL are not yet available.

Several etiological factors can cause SHL, such as loud noise \[[@B17-ijerph-17-01969],[@B18-ijerph-17-01969]\], viral infection \[[@B14-ijerph-17-01969],[@B19-ijerph-17-01969]\], genetic mutations \[[@B20-ijerph-17-01969],[@B21-ijerph-17-01969]\], accidental events \[[@B22-ijerph-17-01969],[@B23-ijerph-17-01969]\], ototoxicity \[[@B24-ijerph-17-01969],[@B25-ijerph-17-01969],[@B26-ijerph-17-01969]\], autoimmune diseases \[[@B27-ijerph-17-01969]\] and unknown illness-induced sudden SHL \[[@B28-ijerph-17-01969],[@B29-ijerph-17-01969]\]. Several diseases such as hypertension (HT) \[[@B30-ijerph-17-01969],[@B31-ijerph-17-01969]\], diabetes mellitus (DM) \[[@B32-ijerph-17-01969],[@B33-ijerph-17-01969]\], stroke \[[@B34-ijerph-17-01969]\], chronic kidney disease (CKD) \[[@B35-ijerph-17-01969],[@B36-ijerph-17-01969]\], ischemic heart disease (IHD) \[[@B37-ijerph-17-01969],[@B38-ijerph-17-01969]\], alcoholism \[[@B39-ijerph-17-01969],[@B40-ijerph-17-01969]\], nicotine dependence \[[@B41-ijerph-17-01969],[@B42-ijerph-17-01969]\], asthma \[[@B43-ijerph-17-01969],[@B44-ijerph-17-01969],[@B45-ijerph-17-01969]\], chronic obstructive pulmonary disease (COPD) \[[@B46-ijerph-17-01969]\], and rheumatoid arthritis (RA) \[[@B47-ijerph-17-01969]\] are associated with SHL. Notably, some of these diseases can cause defects in the vascular system and microcirculation in the cochlea, subsequently resulting in hypoxia \[[@B48-ijerph-17-01969],[@B49-ijerph-17-01969],[@B50-ijerph-17-01969]\]. Hypoxia has been demonstrated to damage the HCs and neurons in the inner ear \[[@B48-ijerph-17-01969],[@B50-ijerph-17-01969]\]. Furthermore, it has been shown that hypoxia-inducible factor-1α is upregulated by cobalt chloride-induced hypoxia in noise-induced hearing loss \[[@B51-ijerph-17-01969]\].

Accumulating evidence using the analyses of the National Health Insurance Research Database (NHIRD) in Taiwan shows that chronic exposure to air pollution increases the risk of neurodegenerative diseases including Parkinson's disease (PD) \[[@B9-ijerph-17-01969]\], dementia \[[@B10-ijerph-17-01969]\], and AMD \[[@B11-ijerph-17-01969]\]. Although air pollution has been considered a risk factor for several diseases, its association with hearing disorders has been less studied. A previous study conducted in Busan, Korea, showed that air pollution is possibly associated with sudden SHL \[[@B52-ijerph-17-01969]\]. However, whether air pollution is associated with SHL remains controversial. Therefore, it is significantly interesting to hypothesize that air pollution may also be associated with SHL development. In this study, we focused on investigating the two major traffic-related air pollutants: nitrogen dioxide (NO~2~) and carbon monoxide (CO). We analyzed the data from a longitudinal cohort study using the Taiwan National Health Insurance (NHI) data to assess the significant effects of these traffic-related air pollutants to SHL.

2. Subjects and Methods {#sec2-ijerph-17-01969}
=======================

2.1. Data Source and Study Subjects {#sec2dot1-ijerph-17-01969}
-----------------------------------

A single-payer Taiwan NHI program was launched in March 1995. Approximately 99% of Taiwan's population are included in this program. The NHIRD consists of insured's inpatients and outpatient claims, medications, and treatment data. In the present study, we utilized the Longitudinal Health Insurance Database which is the health database of a million beneficiaries randomly selected from the NHIRD. The identification information was encrypted to protect the patients' personal privacy. The disease codes were identified according to the International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM). We recruited subjects aged older than 20 years with no history of SHL from 1998 to 2010, and they were followed up until SHL was observed, they withdrew from the NHI program, and the study ended (December 2011).

2.2. Exposure Measurement {#sec2dot2-ijerph-17-01969}
-------------------------

The data regarding the air pollutants were collected from 74 ambient air quality monitoring stations across Taiwan. The air quality data are managed by Taiwan Environmental Protection Administration. The annual concentrations of NO~2~ and CO from 1998 to 2010 were grouped into the following three levels according to tertiles: the low-, mid-, and high-level groups. The NO~2~ concentrations of the low-, mid-, and high-level groups were \<19.53 (ppb), 19.53--25.66 (ppb), and \>25.66 (ppb), respectively. Moreover, the CO concentrations of the low-, mid-, and high-level groups were \<0.61 (ppm), 0.61--0.76 (ppm), and \>0.76 (ppm), respectively. To analyze the exposures across a 13 year period (from 1998 to 2010), we calculated the annual average of pollutants from baseline to the date of hearing loss occurrence.

2.3. Main Outcome and Covariates {#sec2dot3-ijerph-17-01969}
--------------------------------

Hearing loss (ICD-9-CM code 389.10--389.12 and 388.01) was the primary event in this study. Besides age and sex, we also considered the insurance fee and area of residence of the subjects. The common comorbidities including HT (ICD-9-CM codes 401--405) \[[@B30-ijerph-17-01969],[@B31-ijerph-17-01969]\], DM (ICD-9-CM code 250) \[[@B32-ijerph-17-01969],[@B33-ijerph-17-01969]\], stroke (ICD-9-CM codes 430--438) \[[@B34-ijerph-17-01969]\], head injury (ICD-9-CM codes 850--854) \[[@B22-ijerph-17-01969],[@B23-ijerph-17-01969]\], CKD (ICD-9-CM code 585) \[[@B35-ijerph-17-01969],[@B36-ijerph-17-01969]\], IHD (ICD-9-CM codes 410--414) \[[@B37-ijerph-17-01969],[@B38-ijerph-17-01969]\], alcoholism (ICD-9-CM codes 305.0 and 303) \[[@B39-ijerph-17-01969],[@B40-ijerph-17-01969]\], nicotine dependence (ICD-9-CM code 305.1) \[[@B41-ijerph-17-01969],[@B42-ijerph-17-01969]\], asthma (ICD-9-CM code 493) \[[@B43-ijerph-17-01969],[@B44-ijerph-17-01969],[@B45-ijerph-17-01969]\], COPD (ICD-9-CM codes 490--492, 494, and 496) \[[@B46-ijerph-17-01969]\], and RA (ICD-9-CM code 714) \[[@B47-ijerph-17-01969]\] were considered as potential confounders.

2.4. Statistical Analysis {#sec2dot4-ijerph-17-01969}
-------------------------

We show the demographic distribution as a percentage. The incidence density rates of hearing loss were calculated, and the incidence rate ratio (IRR) was assessed by Poisson regression. We estimated the hazard ratios using the multivariate Cox proportional hazard model, adjusting for age, sex, insurance fee, urbanization, and comorbidities.

3. Results {#sec3-ijerph-17-01969}
==========

We recruited 75,767 subjects in the present study. [Table 1](#ijerph-17-01969-t001){ref-type="table"} shows the distribution of the demographic characteristics of the study sample. The subjects' mean age was 54.1 (±11.1) years with a mean age of 11.1 (±2.2) years the following years. Moreover, 45.3% of the subjects were men. The subjects were evenly exposed to low-, mid-, and high-level CO and NO~2~. Most of the subjects lived in moderately urbanized areas (33.1%) and highly urbanized areas (32.5%). [Table 2](#ijerph-17-01969-t002){ref-type="table"} shows that the top three comorbidities with high incidence rates were HT (57.5%), DM (20.6%), stroke (9.1%), head injury (9.8%), CKD (5.3%), IHD (34.6%), alcoholism (1.4%), nicotine dependence (2.2%), asthma (17.5%), COPD (34.5%), and RA (0.5%).

The IRRs of SHL in different air pollutant exposure levels are presented in [Table 3](#ijerph-17-01969-t003){ref-type="table"}. Subjects exposed to low-level air pollutants were assigned to the reference group. The IRR of SHL in subjects exposed to high-level CO was 1.24 (95% confidence interval (CI) = 1.14--1.36). The NO~2~ pollutants increased the incidence of SHL in subjects exposed to mid-level NO~2~ and high-level NO~2~ by 1.10 (95% CI = 1.10--1.32) and 1.36 (95% CI = 1.24--1.49) times, respectively. From our analyses, the CO levels in highly urbanized region, moderately urbanized region, boomtown, and others were 0.82 ± 0.31, 0.69 ± 0.24, 0.71 ± 0.22, and 0.58 ± 0.21, respectively ([Table 3](#ijerph-17-01969-t003){ref-type="table"}). Furthermore, the NO~2~ levels in highly urbanized region, moderately urbanized region, boomtown, and others were 24.69 ± 6.65, 21.83 ± 6.45, 23.54 ± 5.53, 17.87 ± 6.37, respectively ([Table 3](#ijerph-17-01969-t003){ref-type="table"}). Our results suggest that the distribution of CO and NO~2~ levels are highly correlated with the urbanization.

According to [Table 4](#ijerph-17-01969-t004){ref-type="table"}, the adjusted hazard ratio (adj. HR) of SHL in subjects exposed to high-level CO was 1.45 (95% CI = 1.31--1.59), relative to that of subjects exposed to low-level CO. Compared to subjects exposed to low-level NO~2~, subjects exposed to mid-level NO~2~ (adj. HR = 1.40, 95% CI = 1.27--1.54) and high-level NO~2~ (adj. HR = 1.63, 95% CI = 1.48--1.81) had a higher risk of developing SHL. Moreover, the increased risk of SHL following the increased concentrations of air pollutants (CO and NO~2~) was statistically significant in this study. In the present study, we found that the incidence rate ratio of SHL in the highest level of CO (IRR = 1.24, 95%CI = 1.14--1.36) was significantly higher than that in low level of CO ([Table 4](#ijerph-17-01969-t004){ref-type="table"}). Furthermore, we found that the incidence rate ratio of SHL in the mid-level (IRR = 1.21, 95% CI = 1.10--1.32) and highest level of NO~2~ (IRR = 1.36, 95% CI = 1.24--1.49) was significantly higher than that in low level of NO~2~ ([Table 4](#ijerph-17-01969-t004){ref-type="table"}).

According to [Table 5](#ijerph-17-01969-t005){ref-type="table"}, the aHR of hearing loss in the high CO concentration group relative to the low CO concentration group was 1.45 (95% CI, 1.31--1.59). Patients in the mid-NO~2~ level (aHR = 1.40, 95% CI = 1.27--1.54) and high NO~2~ level (aHR = 1.63, 95% CI = 1.48--1.81) groups had a higher risk of hearing loss compared to patients in the low NO~2~ level group. The increased concentrations of the air pollutants (i.e., CO and NO2) enhancing the risk of hearing loss was statistically significant. Moreover, continuous analyses based on the subjects' sex and age (subjects aged 50 years) to assess the association between air pollution and SHL were performed. Our data suggest that both male (aHR = 1.25, 95% CI = 1.03--1.52) and female (aHR = 1.49, 95% CI = 1.20--1.85) subjects have a significantly high incidence of SHL when they are exposed to CO pollution. Moreover, female subjects had a significantly high incidence of SHL when exposed to NO2 (aHR = 1.01, 95% CI = 1.001--1.02). Furthermore, elderly subjects aged greater than 50 years had a significantly higher risk of SHL (CO: aHR = 1.37, 95% CI = 1.17--1.62) when they were exposed to CO pollution. Additionally, we provided the probability-free prediction of SHL among the three levels of CO and NO2 concentrations ([Figure 1](#ijerph-17-01969-f001){ref-type="fig"}).

4. Discussion {#sec4-ijerph-17-01969}
=============

Although air pollution has been considered a risk factor for several diseases, its association with hearing disorders has been less studied. In this study, we hypothesized that air pollution may also be associated with SHL development. We focused on investigating the two major traffic-related air pollutants: nitrogen dioxide (NO2) and carbon monoxide (CO). We analyzed the data from a longitudinal cohort study using Taiwan National Health Insurance (NHI) data to assess the significant effects of these traffic-related air pollutants to SHL. Our results revealed that the subjects who were chronically exposed to air pollution were at a significantly increased risk of developing SHL. Based on the longitudinal human data, our results suggest that NO~2~ and CO could have potential adverse effects on SHL. Furthermore, we showed that long-term exposure to the highest quartile of NO~2~ significantly increased the risk of SHL by almost 1.63 fold, even after adjusting the confounding factors. Additionally, exposure to the highest quartile of CO also increased the risk of SHL by 1.45 fold. Nitrogen dioxide and CO result in cellular damages through different mechanisms. Nitrogen dioxide is a reactive nitrogen species (RNS). Reactive nitrogen species and reactive oxygen species cause cell apoptosis. On the contrary, CO is considered toxic, as it prevents the blood system from effectively carrying oxygen around the body, specifically to the vital organs such as the heart and brain. However, any report showing the association between CO and SHL does not exist yet. The present study suggests that exposure to CO and NO~2~ has several adverse effects on the auditory system.

Several studies investigating the clinical effects of air pollution on different organ systems in the human body have been conducted \[[@B4-ijerph-17-01969],[@B7-ijerph-17-01969],[@B8-ijerph-17-01969],[@B9-ijerph-17-01969],[@B11-ijerph-17-01969],[@B53-ijerph-17-01969]\]. Using similar datasets, we have previously shown that CO and NO~2~ were associated with AMD \[[@B11-ijerph-17-01969]\], dementia \[[@B53-ijerph-17-01969]\], and PD \[[@B9-ijerph-17-01969]\]. Compared with the lowest exposure group, the adj. HRs for AMD and dementia were 1.91 and 1.5 and 1.84 and 1.61 for the highest quartile of NO~2~ exposure and the highest quartile of CO exposure, respectively. Based on the adj. HRs, our data indicated that these two pollutants have similar adverse effects on SHL, AMD, and dementia. On the contrary, either NO~2~ or CO is not associated with the incidence of PD. However, particulate matter 10 (PM~10~) exposure can have significant adverse effects on PD development. Similar to AMD and dementia, SHL is also an age-related disease that primarily affects the cochlear hair cells and spiral ganglion neurons.

The onset of SHL has been associated with several risk factors including inflammation and oxidative stress. Our data further suggest that RNS might also contribute to SHL progression. Nitrogen dioxide is one of the most important components of traffic-related air pollution. It can be hydrolyzed to nitrous and nitric acid, both of which can induce inflammation by oxidative stress and lipid peroxidation. It has been suggested that gentamicin application intratympanally can result in a hearing threshold shift beginning on the second day after gentamicin application. This hearing impairment is simultaneously associated with an increased NO~2~^−^ (a stable oxidation product of NO~2~) concentration in the lateral wall, indicating that NO~2~^−^ contributes to gentamicin-induced hearing impairment \[[@B54-ijerph-17-01969]\].

Although the primary route of exposure to NO~2~ is via inhalation, studies assessed not only the association between the respiratory system and NO~2~ exposure but also the association between the cardiovascular \[[@B55-ijerph-17-01969],[@B56-ijerph-17-01969]\] and neurological systems and NO~2~ exposure \[[@B57-ijerph-17-01969]\]. Previously, air pollution has been reported to be a risk factor for sudden SHL \[[@B52-ijerph-17-01969]\]. The major differences between our results and the reports of Lee et al. \[[@B52-ijerph-17-01969]\] are as follows: (1) our study was the first study to use a large longitudinal cohort from 1998 to 2010 to demonstrate the significant association between SHL and high levels of ambient NO~2~ and CO. (2) According to the report of Lee et al. \[[@B52-ijerph-17-01969]\], they utilized the data from the daily patient numbers admitted to the hospital with sudden SHL in 2015 and demonstrated that in Busan, Korea, there is a statistically significant weak association between the daily numbers of patients admitted to the hospital with sudden SHL and the exposure of mean daily PM~10~ and PM~2.5~ concentrations \[[@B52-ijerph-17-01969]\].

It has been suggested that the risk of SHL is also significantly associated with factory workers who are co-exposed to noise and heavy metals or organic solvents \[[@B58-ijerph-17-01969]\]. Co-exposure to noise and heavy metal or toxic pollution results in a worse SHL compared with isolated exposures \[[@B59-ijerph-17-01969]\]. In the present study, both CO and NO~2~ levels are relatively higher in highly urbanized region and boomtown than in other areas ([Table 3](#ijerph-17-01969-t003){ref-type="table"}). Notably, both noise and air pollution may damage the cochlear HCs via oxidative stress \[[@B60-ijerph-17-01969]\], hypoxia-induced reactive oxygen species, and HC damage \[[@B48-ijerph-17-01969]\]. Although we found a statistically significant association between air pollution and subsequent SHL, the present study had the following limitations that need to be considered: (1) The noise levels in the studied area and the genetic variants in the studied subjects, which are considered as important risk factors for SHL, were not clarified in the present study, and without the noise-level data, the scope and significance of the study are limited. (2) The study conducted in the assigned residential area was according to the subject's condition which was associated with the treatment of acute upper respiratory infections in a clinic or hospital, resulting in the underestimation of every subject's exposure level to each air pollutant in the studied area. However, our findings are still significant and require further investigation. (3) In the present study, we used the ICD-9-CM codes 389.10--389.12 and 388.01 for data acquisition of age-related hearing loss and SHL. However, we did not include the ICD-9-CM codes of sudden hearing loss (388.02) and conductive hearing loss (389.00 and 389.06) considering that only 3.6% (2724 SHL subjects/75,767 subjects) of the subjects were identified as SHL patients in this study ([Table 1](#ijerph-17-01969-t001){ref-type="table"}).

5. Conclusions {#sec5-ijerph-17-01969}
==============

In conclusion, we linked the national health database and air quality database to report NO~2~ and CO as risk factors for SHL. Our results indicate that the highest quartile of each pollutant could increase the risk of SHL by almost 1.63 and 1.45 fold, respectively. Notably, a mid-level exposure to NO~2~, but not CO, could also significantly contribute to SHL development by 1.40 fold.
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ijerph-17-01969-t001_Table 1

###### 

Distribution of the demographic data of the study participants.

  ---------------------------------------------------------------------------------------------------------------------------
  Covariates       Categories   Hearing Loss\   Without Hearing Loss\   *p*      Total\                              
                                (*n* = 2724)    (*n* = 73,043)                   (*n* = 75,767)                      
  ---------------- ------------ --------------- ----------------------- -------- ---------------- --------- -------- --------
  Age              Mean (SD)    60.8            (11.6)                  53.9     (11.0)           \<0.001   54.1     (11.1)

  Follow years     Mean (SD)    6.3             (3.4)                   11.3     (1.9)            \<0.001   11.1     (2.2)

  Male                          1569            57.6                    32,791   44.9             \<0.001   34,360   45.3

  Insurance fee\   \>17,400     1148            42.1                    22,948   31.4             \<0.001   24,096   31.8
  (NTD)                                                                                                              

  17,400--19,200   884          32.5            25,686                  35.2                      26,570    35.1     

                   \>19,200     692             25.4                    24,409   33.4                       25,101   33.1

  Urbanization     Highly       815             29.9                    23,838   32.6             \<0.001   24,653   32.5

                   Moderately   921             33.8                    24,186   33.1                       25,107   33.1

                   Boomtown     362             13.3                    11,817   16.2                       12,179   16.1

                   Others       626             23.0                    13,202   18.1                       13,828   18.3

  CO               Low          918             33.7                    24,800   34.0             \<0.001   25,718   33.9

                   2nd          717             26.3                    24,187   33.1                       24,904   32.9

                   High         1089            40.0                    24,056   32.9                       25,145   33.2

                   Mean (SD)    0.72            (0.27)                  0.71     (0.27)           0.313     0.71     (0.27)

  NO~2~            Low          834             30.6                    26,178   35.8             \<0.001   27,012   35.7

                   2nd          909             33.4                    23,839   32.6                       24,748   32.7

                   High         981             36.0                    23026    31.5                       24,007   31.7

                   Mean (SD)    22.10           (7.32)                  22.31    (6,76)           0.129     22.31    (6.78)
  ---------------------------------------------------------------------------------------------------------------------------

CO: carbon monoxide; NO~2~: nitrogen dioxide; NTD: new Taiwan dollar.

ijerph-17-01969-t002_Table 2

###### 

Distribution of the comorbidities of the study participants.

  ---------------------------------------------------------------------------------------------------------
  *n*, %        Hearing Loss\   Without Hearing Loss\   *p*      Total\                              
                (*n* = 2724)    (*n* = 73,043)                   (*n* = 75,767)                      
  ------------- --------------- ----------------------- -------- ---------------- --------- -------- ------
  HT            1728            63.4                    41,813   57.2             \<0.001   43,541   57.5

  DM            519             19.1                    15,105   20.7             0.042     15,624   20.6

  Stroke        208             7.6                     6683     9.1              0.008     6891     9.1

  Head injury   267             9.8                     7135     9.8              0.980     7402     9.8

  CKD           139             5.1                     3846     5.3              0.742     3985     5.3

  IHD           1201            44.1                    25,007   34.2             \<0.001   26,208   34.6

  Alcoholism    26              1.0                     1019     1.4              0.064     1045     1.4

  Nicotine      32              1.2                     1599     2.2              \<0.001   1631     2.2

  Asthma        495             18.2                    12,779   17.5             0.375     13,274   17.5

  COPD          1208            44.3                    24,954   34.2             \<0.001   26,162   34.5

  RA            11              0.4                     352      0.5              0.661     363      0.5
  ---------------------------------------------------------------------------------------------------------

HT: hypertension; DM: diabetes mellitus; CKD: chronic kidney disease; IHD: ischemic heart disease; Nicotine: nicotine dependence; COPD: chronic obstructive pulmonary disease; RA: rheumatoid arthritis.

ijerph-17-01969-t003_Table 3

###### 

Distributions of NO~2~ and CO among urbanization zones.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------
  *n*, %   Highly Urbanized\   Moderately Urbanized\   Boomtown\        Others\          Total\                                                        
           (*n* = 24,653)      (*n* = 25,107)          (*n* = 12,179)   (*n* = 13,828)   (*n* = 75,767)                                                
  -------- ------------------- ----------------------- ---------------- ---------------- ---------------- -------------- ------ ------ ------ -------- ------
  CO       Low                 4891                    19.8             8729             34.8             3828           31.4   8270   59.8   25,718   33.9

           2nd                 6718                    27.3             9220             36.7             5056           41.5   3910   28.3   24,904   32.9

           High                13,044                  52.9             7158             28.5             3295           27.1   1648   11.9   25,145   33.2

           Mean (SD)           0.82 (0.31)             0.69 (0.24)      0.71 (0.22)      0.58 (0.21)      0.71 (0.27)                                  

  NO~2~    Low                 5709                    23.2             9841             39.2             2912           23.9   8550   61.8   27,012   35.7

           2nd                 5851                    23.7             9334             37.2             5627           46.2   3936   28.5   24,748   32.7

           High                13,093                  53.1             5932             23.6             3640           29.9   1342   9.7    24,007   31.7

           Mean (SD)           24.69 (6.65)            21.83 (6.45)     23.54 (5.33)     17.87 (6.37)     22.31 (6.78)                                 
  -----------------------------------------------------------------------------------------------------------------------------------------------------------

ijerph-17-01969-t004_Table 4

###### 

Incidence and incidence rate ratio of hearing loss for the three levels of air pollutant exposure.

  Pollutants   Levels   *n* of HL   Follow Years   IR     IRR    95%CI
  ------------ -------- ----------- -------------- ------ ------ ------------
  CO           Low      918         287,414        3.19   1.00   
               2nd      717         282,256        2.54   0.79   0.72--0.88
               High     1089        274,908        3.96   1.24   1.14--1.36
  NO~2~        Low      834         304,577        2.74   1.00   
               2nd      909         275,599        3.30   1.21   1.10--1.32
               High     981         264,401        3.71   1.36   1.24--1.49

PY: person-years; *n* of HL: number of patients with hearing loss; IR: incidence rate (per 1000 person-years); IRR: incidence rate ratio.

ijerph-17-01969-t005_Table 5

###### 

Adjusted HR of hearing loss in the moderate and high concentration groups compared to that in the low concentration group.

  Pollutants   Levels            All    Sex-Specific Risk   Age-Specific Risk                                                                     
  ------------ ----------------- ------ ------------------- ------------------- -------------- ------------- --------- ------------- ------------ ---------
  CO           continuous        1.35   1.17--1.56          \<0.001             1.25^male^     1.03--1.52    \<0.001   1.30^\<=50^   0.97--1.74   0.084
               2nd versus Low    0.90   0.82--1.00          0.050               0.88^male^     0.77--1.01    0.064     1.00^\<=50^   0.81--1.23   0.995
               High versus Low   1.45   1.31--1.59          \<0.001             1.38^male^     1.22--1.57    \<0.001   1.65^\<=50^   1.35--2.03   \<0.001
               continuous                                                       1.49^female^   1.20--1.85    \<0.001   1.37^\>50^    1.17--1.62   \<0.001
               2nd versus Low                                                   0.94^female^   0.81--1.10    0.459     0.88^\>50^    0.79--0.99   0.034
               High versus Low                                                  1.53^female^   1.32--1.77    \<0.001   1.394^\>50^   1.25--1.55   \<0.001
  NO~2~        continuous        1.01   1.001--1.01         0.024               1.01^male^     1.00--1.01    0.215     1.01^\<=50^   1.00--1.02   0.168
               2nd versus Low    1.40   1.27--1.54          \<0.001             1.38^male^     1.21--1.56    \<0.001   1.45^\<=50^   1.18--1.79   \<0.001
               High versus Low   1.63   1.48--1.81          \<0.001             1.56^male^     1.36--1.78    \<0.001   1.92^\<=50^   1.55--2.37   \<0.001
               continuous                                                       1.01^female^   1.001--1.02   0.031     1.01^\>50^    1.00--1.01   0.057
               2nd versus Low                                                   1.41^female^   1.22--1.64    \<0.001   1.39^\>50^    1.25--1.55   \<0.001
               High versus Low                                                  1.73^female^   1.49--2.02    \<0.001   1.56^\>50^    1.40--1.75   \<0.001

Adjusted HR: adjusted hazard ratio in the multivariate analysis after adjusting for age, sex, insurance fee, urbanization, HT, DM, stroke, head injury, CKD, IHD, alcoholism, nicotine dependence, asthma, and COPD.

[^1]: First authors.
